Tectonic Therapeutic | AVRO - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Celltrion KRW 49.87B 20.22B 2025-12
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Gilead Sciences USD 7.56B 234M 2025-12
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
MacroGenics USD 66.52M 9.3M 2026-03
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pfizer USD 1.7B 561M 2026-03
Pharma Mar EUR 48.86M 31.05M 2026-03
Qiagen NV USD 839M 516.58M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Sartorius EUR 573.8M 32.4M 2026-03
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Takeda JPY 654.94B 26.55B 2025-12
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03